Preparation and characterization of curcumin-piperine dual drug loaded nanoparticles

来源 :Asian Pacific Journal of Tropical Biomedicine | 被引量 : 0次 | 上传用户:ymlazy64
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Objective:To prepare curcumin-piperine(Cu-Pi) nanoparticles by various methods and to study the effect of various manufacturing parameters on Cu-Pi nanoparticles and to identify a suitable method for the preparation of Cu-Pi nanoparticles to overcome oral bioavailability and cancer cell targeting limitations in the treatment of cancer.Methods:Cu-Pi nanoparticles were prepared by thin film hydration method,solid dispersion method,emulsion polymerization method and Fessi method.Optimization was carried out to study the effect of various manufacturing parameter on the Cu-Pi nanoparticles.Results:Out of four methods,Fessi method produced a minimum average particle size of 85.43 nm with a polydispersity index of 0.183 and zeta potential of 29.7 mV.Change of organic solvent(acetone or ethanol) did not have any significant effect on Cu-Pi nanoparticles.However,increase in sonication time,stirring speed,viscosity,use of 1:10:10 ratio of drag/polymer/surfactant,and use of anionic surfactant or combination of anionic surfactant with cationic polymer or combination of non-ionic surfactant with cationic polymer had a significant effect on Cu-Pi nanoparticles.Conclusions:Cu-Pi nanoparticles coated with PEC containing copolymer produced by Fessi method had a minimum average particle size,excellent polydispersity index and optimal zeta potential which fall within the acceptable limits of the study.This dual nanoparticulate drug delivery system appears to be promising to overcome oral bioavailability and cancer cell targeting limitations in the treatment of cancer. Objective: To prepare curcumin-piperine (Cu-Pi) nanoparticles by various methods and to study the effect of various manufacturing parameters on Cu-Pi nanoparticles and to identify a suitable method for the preparation of Cu-Pi nanoparticles to overcome oral bioavailability and cancer cell targeting limitations in the treatment of cancer. Methods: Cu-Pi nanoparticles were prepared by thin film hydration method, solid dispersion method, emulsion polymerization method and Fessi method. Optimization was carried out to study the effect of various manufacturing parameters on the Cu- Pi nanoparticles. Results: Out of four methods, Fessi method produced a minimum average particle size of 85.43 nm with a polydispersity index of 0.183 and zeta potential of 29.7 mV. Change of organic solvent (acetone or ethanol) did not have any significant effect on Cu-Pi nanoparticles. However, increase in sonication time, stirring speed, viscosity, use of 1:10:10 ratio of drag / polymer / surfactant, and use of anionic surfactant or combination of anionic surfactant with cationic polymer or combination of non-ionic surfactant with cationic polymer had a significant effect on Cu-Pi nanoparticles. Conclusions: Cu-Pi nanoparticles coated with PEC containing copolymer produced by Fessi method had a minimum average particle size, excellent polydispersity index and optimal zeta potential which fall within the acceptable limits of the study. This dual nanoparticulate drug delivery system appears to be promising to overcome oral bioavailability and cancer cell targeting limitations in the treatment of cancer.
其他文献
周围神经再生是一个倍受关注的课题.近年来,在大量针灸临床治疗周围神经再生有效的基础上,进行了相关的实验研究,显示出针灸在治疗促进周围神经再生方面的独特优势,现将有关
AIM: To prospectively investigate serum CA 19-9 levels in type 2 diabetic patients in comparison with age- and gender-matched control subjects. METHODS: We reco
期刊
目的 规范糖尿病住院患者床旁血糖监测棉签收集,提高棉签收集的依从性.方法 2017年9月10日~2018年3月10日在糖尿病病区观察住院患者600例,随机分为对照组和实验组,对照组棉签
期刊
@@
目的 评价经上皮准分子激光角膜切削术(TPRK)治疗近视和散光的临床效果.方法 回顾性病例对照研究.纳入行TPRK的近视和近视散光患者38例(72眼)作为TPRK组,选择准分子激光上皮
动脉粥样硬化(AS)是一种常见病、多发病,是多种心脑血管疾病的病理基础.大量的动物实验已证实中医药可作用于AS发生、发展的各个环节.但人类AS的发生、发展复杂而漫长,是几十
目的:探究老年糖尿病患者发生低血糖的原因分析和护理对策.方法:选取我院2017年7月~2018年6月收治的70例老年糖尿病患者的临床资料进行回顾性分析.结果:老年糖尿病患者发生低
34例住院患者,均为经合理给予洋地黄、利尿剂、血管转换酶抑制剂、硝酸酯类、纠正病因诱因、吸氧治疗仍无效或者加重的患者.原发病为扩张性心肌病13例,风湿性心脏病8例,冠心
目的用失效模式和效应分析(FMEA)法探讨静脉用茶碱类药物管理过程发生用药错误的风险点,改进管理措施,提高用药安全性。方法应用FMEA法对解放军总医院第一附属医院和哈尔滨医科大学附属第一医院静脉用茶碱类药品流通全环节可能存在的安全隐患进行分析,计算风险优先级数(RPN),以RPN>216分的风险点为静脉用茶碱类药物管理过程中的关键风险点,针对这些风险点制定管理和技术策略,比较管理措施改进前后的防范